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Abstract Patientswith asthma-like symptomsbutwithnegative asthmatests are oftenmisdiagnosedashavingasthma
andtreatedas asthmatics.Theydescribetheir trigger factors andsymptomsverysimilar tothoseofpatientswithasthma.
The aimofthe studywas to analyze differences in symptoms and trigger factors between asthma-like patients and asth-
maticsin order to elaborate a basis for a questionnaire forepidemiological andclinicaluse.Aquestionnairewith 54 ques-
tions abouttrigger factors and137 questions about symptomswas sentto 40 patientswith asthma-like symptoms and 40
with asthma, allconsecutively selected frompatientsreferredto anout-patientclinic for asthma andallergy forinvestiga-
tion of suspected asthma.Datawere analyzed statistically in two steps usingmultiple logistic regression analysis. Signifi-
cantdifferenceswere seeninseveraltrigger factors andsymptomsafter the first analysis.After the secondanalysis, seven
out of the 54 trigger factors and 22 out of the 137 symptoms emerged as those that most significantly discriminated
between the two patient groups.These trigger factors and symptoms can be the basis of a newquestionnairewith high
discriminatingpower.Beforeusingit, itisimportantto evaluatethebestcombinationof variables, addsomedemographic
variables and to testthe reliability andvalidityofthis newquestionnaire.r2002 Elsevier Science Ltd
doi:10.1053/rmed.2001.1281, available online athttp://www.idealibrary.comon
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Patients reporting asthma-like symptoms without having
positive asthma tests have been described in several
studies (1^9). Hyperventilation (4) and a sensory airway
hyperreactivity have been proposed as underlying me-
chanisms in this asthma-like disorder (8). Characteristic
of this kind of patient is complaints of asthma-like symp-
toms such as cough, increased phlegm, di⁄culty in get-
ting air and heavy breathing. Chemical irritants like
tobacco smoke, perfumes and exhaustgases and physical
exercise, cold air or mental stress often trigger the
symptoms. In patients in whom the diagnosis is based
only on the history, the patientmay receive the diagnosis
asthma, as the symptoms are very similar. However, aReceived 22 June 2001, accepted in revised form12 December 2001.
Correspondence should be addressed to: KCRingsbergThe Nordic
School of Public Health, box12133, S-402 42 G˛teborg, Sweden.Fax:
+46 (0)31691777; E-mail: karin@nhv.seproper clinical examination with asthma tests such as
forced expiratory volume in one second (FEV1), peak ex-
piratory £owrate (PEFR), tests of reversibility and varia-
bility and a methacholine challenge test will show that
these patients do not have any objective signs of bron-
chial asthma. Steroids, b2-stimulants and other pharma-
cological treatment seem to have no or only slight e¡ect.
The prevalence in the general population of this asthma-
like disorder isnotyetknownbutit is estimated to1% from
studies performed in patients with asthma (5).Therefore,
there is a need for a questionnaire that can be used in epi-
demiological studies. There is also a need for a question-
naire that can be used in the clinical setting for diagnostic
purposes complementary to the lung function tests.
The aim of the present study was to analyze di¡er-
ences in symptoms and trigger factors between patients
with asthma-like symptoms and patients with asthma in
order to elaborate a basis for a questionnaire for epide-
miological and clinical use.
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Conduct of the study
First a self-administered, structured questionnaire
including 54 trigger factors and 137 symptoms was
constructed.This questionnairewas sent to 80well-diag-
nosed, consecutively selected patients, 40 with asthma-
like symptoms and 40 with asthma.Data collected from
these patients were analyzed statistically in two steps
usingmultiple logistic regression analysis in order to ¢nd
those trigger factors and symptoms that most signi¢-
cantly discriminated between the groups.The statistical
analysis resulted in a basis for a new questionnaire with
seven trigger factors and 22 symptoms.
Construction of the questionnaire that was
sent to the patients
The questionnaire sent to the patients consisted of 191
questions and was constructed in three steps as follows.
First, records from 300 patients, not included in this
study, referred to the clinic for investigation of suspected
asthma was studied. The focus was speci¢cally on how
the patients had described their trigger factors and
symptoms in structured questionnaires, used continu-
ously in the clinic for the diagnosis of suspected asthma.
In order also to capture thepatients’own descriptions of
the symptoms and trigger factors, open-endedquestions
and semi-structured interviews used in earlier research
were studied as well (1^4).
Thereafter, the new questionnaire with altogether191
questions (54 questions about trigger factors and 137
questions about symptoms) was constructed.The ques-
tions about trigger factors were grouped in ¢ve subsets
related to: weather (11 items), physical activity (seven
items), psychological stress (four items), odors (20 items)
and dust (12 items).The patients were asked to estimate
the severity of the trigger factors on a ¢ve-point Likert
scale.The scalewas graded: not at all, some, rather a lot,
verymuch, extremelymuch.The questions about symp-
toms were grouped in twelve subsets related to: eyes
(seven items), upper airways and nose (10 items), upper
airways and throat (18 items), lower airways and chest
(28 items), cough (eight items), stomach (seven items),
skin (six items), sleep (10 items), tiredness (four items),
infections (eight items), general symptoms (21 items)
and pain (10 items).The patients were asked to estimate
the frequency of the symptoms on a ¢ve-pointed Likert
scale. The scale was graded: never, occasionally, once a
month, once a week and daily. The patients were also
asked to ¢ll in unstructured comments in connection
with each question.
Finally, before the questionnaire was sent to the
patients, it was checked by a reference group of ten
persons (doctors, nurses and one physiotherapist) allwith several years of clinical experience of both cate-
gories of patients.
Patients
The questionnaire was sent to 80 well-diagnosed
patients, 40 with asthma-like symptoms and 40 with
asthma. Both groups were consecutively selected from
patients referred to an outpatient clinic for asthma and
allergy for investigation of suspected asthma.They were
all diagnosed by doctors specialized in asthma and
allergy.
For inclusion in the asthma-like group (AL-group), the
patients were required to have negative asthma tests i.e.
the following criteria had to bemet:
(1) normal FEV1 or PEFR values before inhalation of a
b2-stimulant de¢ned as 495% of predicted normal
value;
(2) lack of reversibility, de¢ned as an increase of the
FEV1 or PEFR values after inhalation of salbutamol
0?8 mgo10%;
(3) variability o20% of the PEFR values, measured
morning and night for14 consecutive days;
(4) a negative methacholine challenge test de¢ned as
PC208mgml (10);
(5) a negative skin prick test;
(6) no other disease that could have an impact on
respiratory function;
(7) no current smoking;
(8) symptoms reported for at least 2 yrs.
To be included in the asthma group (A-group), at least
two of the following four criteria had to be ful¢lled:
(1) reversibility of the FEV1 or PEFR values 15% after
inhalation of 0?8mg salbutamol (11);
(2) FEV1 or PEFR r80% of predicted normal values
before and490% after inhalation of a b2-stimulant;
(3) a positive methacholine challenge test de¢ned as
PC20r4mgml (10);
(4) variability20% of the PEFRvalues, whenmeasured
morning and night for14 consecutive days (11).
A standardisedmethacholine test was used (10).To be
allowed to start the test, FEV1had to be at least 65% of
predicted value. No bronchodilators were allowed
during a period of 4h (short-acting) or12h (long-acting)
before challenge.The patient inhaledNaCl for 2min, the
FEV1 value after NaCl being the baseline. The challenge
started with the concentration 0?03mgml1. Double
doses were inhaled during two minutes with an interval
of 5minuntil the fall in FEV1was420% or themaximum
dose (16mgml1) was reached. The FEV1 was recorded
two and four minutes after the end of each inhalation.
Results were expressed as PC20 (the concentration
corresponding to 20% fall in FEV1). In the present study





















AL 7/33 41 (20^63) 108 (11?3) 110(11?2) 12(2^50) 32/8 40/0
A 7/33 43 (21^67) 82 (14?4) 95(12?0) 15(2^53) 29/11 17/22
TRIGGERFACTORSANDSYMPTOMS 30729 of the patients with asthma-like symptoms had a
methacholine test with a PC20 416mgml
1, 10 patients
416 and one 8. In the asthma group, 15 had a metha-
choline test with a PC20 varying between 0?1 and
4mgml1.
All patients reported breathing-related symptoms. In
the AL-group 35% (14/40) reported having symptoms
daily, 45% (18/40) sometimes and 20% (8/40) on single
occasions. In the A-group the corresponding ¢gures
were 30% (12/40), 35% (14/40) and 35% (14/40). For
further characteristics of the patients seeTable1.
Thirty-seven (93%) of the patients in the AL-group
were prescribed a b2-stimulant.Twenty-four (60%) took
themedicine, butonly two thought that ithad anye¡ect.
Nonewas prescribed corticosteroids. All the patients in
theA-group (100%)wereprescribed ab2-stimulant.They
all took their medicine and 25 (63%) of them thought
that it had e¡ect. Twenty-six (65%) were prescribed
inhaled corticosteroids (one orally) on a regular basis.
The Ethics Committee of G˛teborg University
approved the study.
Statisticalmethods
Comparisons between the twopatientgroupswere ¢rst
performed with Fisher’s permutation test (12^13) with
respect to all the 191 items (trigger factors and symp-
toms) of the questionnaire.Thereafter, the101items that
di¡ered signi¢cantly between the two groups were
grouped into17 subsets.The itemswithin each subset re-
£ected similar aspects. For each subset of items, a step-
wise logistic regression analysis was applied (14). Before
the second step of the analysis, the number of trigger
factors and symptoms was reduced to17 and 52 respec-
tively items by choosing representatives for each subset.
In this reduction, the following criteria were used: (1)
Each subsetwas to berepresentedby at leastone trigger
factor or symptom. Subsets with many items (e.g.
odours, general factors) should be represented by more
items than subsets with few items (e.g. weather) but not
more than 10; (2) If within the subset two items de-
scribed the same phenomenon, the one that was most
representative and had the lowest signi¢cance level waschosen (e.g. of the psychological items ‘anxiety’, ‘mental
strain’ and ‘con£icting situations and experiences’, con-
£icting situations and experienceswas chosen); (3) Items
that were di¡use (e.g. ‘earth’, ‘leather’ etc.) so that you
really do not know what they measure were omitted.
The items remaining signi¢cant discriminators between
the groups in the series of multiple analyses can be used
to construct a new questionnaire with high discriminat-
ing power.Po0?05 was considered signi¢cant.
Odds ratios and 95% con¢dence intervals are given in
Tables 2 and 3.They can be interpretedwhen comparing
two patients with exactly the samevalues of all variables
except the current one, where the patient correspond-
ing to the numerator is assumed to have one unit higher
value compared to the patient in the denominator. If the
b-coe⁄cient is positive, a higher value of the respective
variable is associatedwith a higher riskof having asthma.
Conversely, if the b-coe⁄cient is negative, a higher value
of the variable is associated with a lower risk of having
asthma. For example, the odds ratio for the trigger
factor ‘warm and dry weather’ is 0?33. This means that
the probability of having asthma is about 67% lower for a
patient compared to another one if the ¢rst patient has
one unit higher value of this trigger factor but is similar
with respect to all other variables of importance. One
unithigher value is attainedif the answer to the question
about warm and dry weather is ‘some’ instead of ‘not at
all’,‘rather a lot’ instead of ‘some’, and so on.
RESULTS
Allwho agreed to join the project also completed it.The
unstructured comments did not add any new informa-
tion to the study and are therefore not reported.
Trigger factors
After the ¢rst statistical analysis, a signi¢cant di¡erence
was seen between the two patient groups in 29 (54%) of
the 54 trigger factors.Themean ratings of the AL-group
were signi¢cantly higher in all these 29 trigger factors
compared to those of the A-group. SeeTable 2, column
2 (¢rst step P-value). In one subset of trigger factors,
TABLE 2. Di¡erences Po0?05 betweenthe AL-group and the A-group intheir ratings of trigger factors
Subsets of Trigger










Warmweather 0?0002 omitted ^
Warm/dryweather 0?0006 0?0015 1?1072 0?33 (0?17,0?65)
Warm/dampweather 0?0431 omitted ^ ^
Psychological ^ ^
Anxiety 0?0188 omitted ^ ^
Mental strain 0?0033 omitted ^ ^
Con£icting situations
and experiences
0?0006 0?0012 0?7056 0?49 (0?32,0?76)
Odours
Perfume 0?0005 NS ^ ^
After shave 0?0016 NS ^ ^
Detergent 0?0042 NS ^ ^
Cleanser 0?0169 omitted ^ ^
Hairspray 0?0001 0?0002 0?7155 0?49 (0?34,0?71)
PrinterŁ s ink 0?0435 omitted ^ ^
Colour paint 0?0045 omitted ^ ^
Glue 0?0355 omitted ^ ^
Plastic 0?0294 omitted ^ ^
Leather 0?0121 omitted ^ ^
Exhaustgases 0?0050 0?0056 0?5072 0?60 (0?42,0?86)
Mould 0?0100 omitted ^ ^
Earth 0?0194 omitted ^ ^
Flowers 0?0177 NS ^ ^
Stu¡y air 0?0035 0?0385 0?4817 0?62 (0?39,0?97)
Smell fromcooking 0?0085 NS ^ ^
Smell fromtobacco 0?0035 0?0038 ^0?5179 0?60 (0?42,0?85)
Smell fromopen ¢re 0?0035 NS ^ ^
Dust ^ ^
Badventilation 0?0060 NS ^ ^
Roomwithmould 0?0029 NS ^ ^
Dust frompaper 0?0226 NS ^ ^
Dust fromdetergent 0?0046 0?0058 0?5260 0?59 (0?41,0?86)
Dust fromcloth 0?0320 NS
308 RESPIRATORYMEDICINE‘Physical activity’, no signi¢cantdi¡erenceswere seenbe-
tween the patient groups and is therefore not presented
in theTable.
In the second analysis, 17 of the 29 trigger factors in
which a signi¢cantdi¡erencebetween thepatient groups
had been found were included.The remaining 12 trigger
factors were omitted. Regarding this procedure see
‘Methods’. Seven of the 17 trigger factors turned out to
be themost signi¢cant discriminating trigger factors be-
tween the two patient groups. SeeTable 2, columns 3^5
(second step P-value, b coe⁄cient, odds ratio).
Symptoms
After the ¢rst statistical analysis, a signi¢cant di¡erence
was seen between the ratings of the frequency of symp-toms in 72 (53%) of the137 symptoms.Themean ratings
of the A-L group were signi¢cantly higher in all the 72
symptoms except for ‘wheezing’ and ‘hissing’. SeeTables
3a and 3b, column 2 (¢rst step P-value).No signi¢cant dif-
ferences between the patient groups were found in the
variables that belonged to the subset ‘Skin’. This subset
is therefore not presented in theTable.
In the second analysis, 52 of the 72 symptoms in
which a signi¢cant di¡erence between the patient
groups had been found were included. The remaining
20 symptoms were omitted. Regarding this procedure
see ‘Methods’. Twenty-two of the 52 symptoms
emergedas those,whichdiscriminatedmost signi¢cantly
between the two patient groups. SeeTables 3a and 3b,
columns 3^5 (second step P-value, b coe⁄cient, odds
ratio).
TABLE 3a. Di¡erences Po0?05 betweenthe AL-group and the A-group intheir ratings of symptoms









Itching 0?0363 NS ^ ^
Dryness 0?0058 0?0084 0?5279 0?59 (0?40,0?87)
Runningeyes 0?0493 omitted ^ ^
Blurredvision 0?0052 NS ^ ^
Upper airways-nose
Itching 0?0016 NS ^ ^
Nasal congestion 0?0177 NS ^ ^
Feeling of swelling in the nose 0?0085 omitted ^ ^
Drymucus 0?0000 0?0187 0?4960 0?61 (0?40,092)
Sensitivity to odours 0?0000 0?0123 0?5155 0?60 (0?40,0?89)
Pain in sinuses 0?0019 NS ^ ^
Upper airways-throat
Itching 0?0327 NS ^ ^
Irritation 0?0022 NS ^ ^
Drymucous 0?0004 0?0176 0?4715 0?62 (0?42,0?92)
Need to clearone’s throat 0?0224 NS ^ ^
Di⁄cultyin swallowingdue to a lump 0?0062 NS ^ ^
Taste of blood 0?0000 0?0033 1?5129 0?22 (0?08,0?60)
Lower airways-chest
Di⁄cultyin gettingair 0?0158 0?0020 0?9955 0?37 (0?20,0?69)
Di⁄cultyin getting oxygen 0?0061 NS ^ ^
Need to take deep breaths 0?0337 NS ^ ^
Di⁄cultyin takingdeep breaths 0?0291 0?0192 0?7233 0?49 (0?26,0?89)
High costalbreathing 0?0383 omitted ^ ^
Whistling in chest 0?0000 omitted ^ ^
Wheezing 0?0002 0?0000 1?7235 5?60 (2?46,12?75)
Hissing 0?046 0?0066 0?9748 2?65 (1?31, 5?36)
Feeling of a tightchest 0?0063 omitted ^ ^
Pressure over chest 0?0005 NS ^ ^
Feeling of sore airways 0?0082 0?0029 1?0745 0?34 (0?17,0?69)
Burning, sore airways 0?0241 omitted ^ ^
Cough
Drycough 0?0071 NS ^ ^
Irritatingcough 0?0038 0?0046 0?5458 0?58 (0?40,0?85)
Stomach
Nausea 0?0000 0?0002 1?2644 0?28 (0?15,0?55)
Need tovomit 0?0004 NS ^ ^
Belching 0?0211 omitted ^ ^
Heartburn 0?0361 omitted ^ ^
Flatulence 0?0024 omitted ^ ^
Diarrhoea 0?0493 omitted ^ ^
Sensation of bloated abdomen 0?003 0?0305 0?4219 0?66 (0?45,0?96)
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The present study shows that patients with asthma-like
symptoms and patients with asthma describe their trig-
ger factors and symptoms very similarly. By using multi-
ple logistic regression analysis, seven out of 54 trigger
factors and 22 out of 137 symptoms were identi¢ed as
those that most signi¢cantly discriminate between the
two patient groups. Of the trigger factors, ‘warm anddry weather’was themost discriminating one.Themost
discriminating symptoms were ‘wake up due to nasal
congestion’, ‘a sore throat’, ‘feeling of confusion’ ‘feeling
of tenseness in the body’, ‘taste of blood’, ‘wheezing’,
‘hissing’,‘feeling of sored airways’ and ‘nausea’.
The patients were selected on strict criteria, used in
earlier studies (1^5).The twopatientgroupshadbeen re-
ferred to a specialist clinic for asthma and allergy and are
therefore not representative of all patients with asthma-
TABLE 3b. Di¡erences Po0?05 betweenthe AL-group and the A-group intheir ratings of symptoms









Sleepingproblems 0?0376 omitted ^ ^
Di⁄cultyin getting to sleep 0?0019 NS ^ ^
Wake up several times duringnight 0?0246 NS ^ ^
Wake up early 0?0239 NS ^ ^
Wake up due to nasal congestion 0?0000 0?0002 1?1059 0?33 (0?18,0?60)
Tiredness
Abnormalgeneral tiredness 0?0040 omitted ^ ^
Abnormal tiredness/weakness after physical exertion 0?0317 omitted ^ ^
Abnormal tiredness/weakness after psychological stress 0?0015 0?0024 0?5962 0?55 (0?37,0?81)
Infection/in£ammation
A sore throat 0?0014 0?0047 1?4209 0?24 (0?09,0?65)
General
Headaches 0?0013 0?0328 0?5905 0?55 (0?32,0?95)
Dizzieness 0?0140 NS ^ ^
Balance problems 0?0120 omitted ^ ^
Fumbling 0?0010 NS ^ ^
Feeling of confusion 0?0000 0?0091 0?9993 0?37 (0?17,0?78)
Palpitations 0?0060 NS
Coldhands and feet 0?0023 0?0384 0?3602 0?70 (0?50,0?98)
Feeling of chilliness 0?0154 omitted ^ ^
Feeling of warmth inthe body 0?0084 omitted ^ ^
Anxious feelings 0?0011 NS ^ ^
Feelings of panic 0?0478 omitted ^ ^
Sti¡ness in ¢ngers and arms 0?0130 NS ^ ^
Tingling ¢ngers andhands 0?0033 NS ^ ^
Loss of sensibilityinthe face 0?0238 omitted ^ ^
Sti¡ness around themouth 0?0105 NS ^ ^
Feeling oftenseness in the body 0?0000 0?001 1?3366 0?26 (0?13,052)
Feeling of illness 0?0003 NS ^ ^
Irritated 0?0021 NS ^ ^
Di⁄cultyin concentrating 0?003 0?0090 0?7037 0?49 (0?29,0?84)
Pain
Pain inthe chest 0?0036 NS ^ ^
Tender to touch in the chest 0?0030 0?0050 0?6511 0?52 (0?33,0?82)
Aches in thewhole body 0?0118 NS ^ ^
Pain/muscle cramp in chest 0?0210 omitted ^ ^
Pain/crampbetween shoulder blades 0?0151 omitted ^ ^
Aches in the joints 0?0244 NS ^ ^
Aches in the airways 0?0024 NS ^ ^
310 RESPIRATORYMEDICINElike symptoms or asthma. However, it is an advantage
that all the patients in this study were diagnosed by a
few doctors, specialized in asthma and allergy, all with
long clinical experience of both patient groups.
Out of 54 trigger factors and 137 symptoms, the pa-
tients of the asthma-like group rated the severity of 29
trigger factors and the frequency of 72 symptoms signi¢-
cantly higher than the patients of the asthma group.
Why? One explanation might be that the patients with
asthma-like symptoms,wise fromearlier experience, felt
that they had to enhance when answering questions/questionnaires in order to be believed, as their asthma
tests are negative. However, in the present study the
asthma-like patients had already had received their ‘diag-
nosis’ at the clinic and were thus con¢rmed in this re-
spect. Another and more likely explanation is that the
patients with asthma-like symptoms in fact experience
more serious problems than the patients with asthma.
It should be noted that in the ¢nal analysis the subsets
‘Physical activity’and ‘Skin’arenotrepresented, as no sig-
ni¢cant di¡erenceswere foundbetween the two patient
groups. Both patient groups rated physical activity high.
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tween three and four, corresponding to the categories
‘rather a lot’ and ‘very much’ for running and jogging. It
is well known that exercise is a trigger of asthma and it
is therefore surprising that no signi¢cant di¡erences
were found between the groups.However, the ¢nding is
supported by two earlier studies (2,9). Regarding the
subset ‘Skin’, both groups scored on average between
two and three, corresponding to the categories ‘occa-
sionally’ and ‘once a month’.
Among the symptoms thatremained as signi¢cant dis-
criminators between the two patient groups, there are
symptoms not only representing the eyes and upper
and lower airways but also other organic systems, some-
times described as ‘general symptoms’. It has been found
in earlier studies that both categories of patients su¡er
from several ‘general symptoms’ but the asthma-like pa-
tients to a higher degree and more frequently (1,3). The
‘general’ symptoms, described by the asthma-like pa-
tients, may be overlooked if too much attention is paid
the airways problems.Moreover, the patientmay not al-
ways mention these symptoms, as he or she may not
think that this is relevant information orwhat the doctor
is interested in.The results of this study illustrate the im-
portance of being open-minded and listening to how the
patients describe their disorder in their ownwords.
Patientswith asthma-like symptomsbutwith negative
asthma tests have been described only for the past 10
years. As this ‘diagnosis’ is not generally recognized,
there is a risk that this kind of patient is still diagnosed
and treated from an asthma perspective. We also see
that patients referred to our clinic for investigation of
asthma have often been improperly diagnosed as asth-
matics. This may happen if the diagnosis is based solely
on the history and not on proper lung function tests, as
the descriptions of symptoms and trigger factors are
quite similar. Likewise, it is very important not to diag-
nose a patient as asthma-like without having seen that
the asthma tests are negative. In future, for diagnostic
purposes, it would be valuable also to add data on
makers of in£ammation, such as blood eosinophils.
Due to lack of suitable diagnostic instruments, the
prevalence of subjects su¡ering from asthma-like symp-
toms but with negative asthma tests has not yet been
studied.From studies in patientswith asthma, the preva-
lence of asthma-like symptoms has been estimated to1%
in an adult population aged 35^36, 50^51 and 65^66
years (15).Using multiple logistic regression analysis, the
present study shows that seven trigger factors and 22
symptoms can later be used as signi¢cant discriminators
between the patient groups when constructing a ques-
tionnairewith high discriminating power for epidemiolo-
gical use for the study of the prevalence of asthma-like
symptoms in large populations. Before this is done, an
evaluation of the best combination of variables must be
made and other variablesmustbe added for example de-mographic variables, how the disorder has developed
and it’s diurnal and seasonal variations.Thequestionnaire
may also be used as a diagnostic instrument complemen-
tary to lung function tests in the clinical setting, but ¢rst
it must be tested with regard to reliability and validity.
This work is now in progress.
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